Cyclerion Therapeutics (CYCN) Cash from Investing Activities (2018 - 2023)

Cyclerion Therapeutics' Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $10.4 million for Q3 2023.

• In Q3 2023, Cash from Investing Activities changed N/A year-over-year to $10.4 million; the TTM figure through Dec 2024 stood at $10.4 million (changed 0.0% YoY), while the FY2023 annual figure was $10.4 million, changed N/A from the prior year.
• Cash from Investing Activities was $10.4 million for Q3 2023 at Cyclerion Therapeutics, up from -$7000.0 in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $10.4 million in Q3 2023 to a low of -$4.2 million in Q2 2019.
• Historically, Cash from Investing Activities has averaged $430166.7 across 4 years, with a median of -$36000.0 in 2020.
• The sharpest annual moves came in 2019 and 2020: Cash from Investing Activities sank 1315.67% in 2019, then soared 1536.0% in 2020.
• A 4-year view of Cash from Investing Activities shows it stood at -$100000.0 in 2019, then jumped by 1536.0% to $1.4 million in 2020, then tumbled by 100.49% to -$7000.0 in 2021, then soared by 148700.0% to $10.4 million in 2023.
• The last three Cash from Investing Activities figures came in at $10.4 million (Q3 2023), -$7000.0 (Q3 2021), and $2000.0 (Q2 2021), per Business Quant data.